Navigation Links
Sanofi Pasteur Dengue Vaccine Enters Pediatric Efficacy Clinical Study
Date:2/18/2009

LYON, France, February 18 /PRNewswire-FirstCall/ --

- Global Clinical Study Program Across Dengue Endemic Regions in Latin America and Asia

Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT : SAN and NYSE : SNY), announced today that its investigational tetravalent dengue vaccine is entering into a pediatric clinical study in Thailand to assess the efficacy of the vaccine in protecting children against dengue, the most widespread tropical disease after malaria. Sanofi Pasteur's tetravalent dengue vaccine candidate is the first to reach this stage of clinical development.

Sanofi Pasteur is collaborating with Mahidol University of Thailand, the Ministry of Public Health, and the Pediatric Dengue Vaccine Initiative (PDVI) to conduct this efficacy study in the province of Ratchaburi.

"Large scale pediatric studies are instrumental for the development of a safe and efficacious dengue vaccine to protect against a disease that primarily affects children," said Dr. Pratap Singhasivanon, Dean of the Faculty of Tropical Medicine, Mahidol University. "We are happy to contribute to an important milestone with the actual start of an efficacy study in Ratchaburi."

The Sanofi Pasteur clinical study program follows guidelines from the Initiative for Vaccine Research (IVR) led by the World Health Organization (WHO), which fosters the global efforts towards dengue vaccine development.

"WHO is committed to the availability of a dengue vaccine that will ultimately benefit children in endemic countries," said Dr. Joachim Hombach, Coordinator Implementation Research for IVR, WHO.

About Sanofi Pasteur dengue vaccine global clinical study program

Sanofi Pasteur started the development of a dengue vaccine in the 90's. Clinical studies with the most advanced tetravalent candidate vaccine started in the 2000's. In a study in the U
'/>"/>

SOURCE Sanofi Pasteur
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
2. Sanofi Pasteur Receives FDA Approval of Meningococcal Vaccine for Children
3. Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine
4. Sanofi Pasteur to Donate 60 Million Doses of H5N1 Vaccine to WHO Over 3 Years for its Influenza Vaccine Global Stockpile
5. Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US
6. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
7. Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed Insulin
8. Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile
9. Demand for VScan Dengue Fever Test Kits Increases
10. U.S. Navy and U.S. Army to Develop Dengue DNA Vaccine Formulated With Vicals Vaxfectin(R) Adjuvant
11. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... /PRNewswire-iReach/ -- VAPETEK™, Inc. has announced a new ... in portable vaporizers, which contains CBD, or cannabodiol. ... cannabidiol offers consumers a THC-free product made for ... technology. Photo - http://photos.prnewswire.com/prnh/20140711/126344 ... compounds which are currently known, two of which ...
(Date:7/11/2014)... 11, 2014 Patient engagement has become ... organizations are turning to an assortment of marketing ... part of this evolving approach to patient engagement, ... and engage patients throughout their experiences with a ... By mapping the patient journey and employing a ...
(Date:7/11/2014)... , July 11, 2014 The ... are evolving across industry sectors to better identify ... better ways to engage with and understand consumers, ... themselves and make critical purchasing decisions. ... Best Practices, LLC, one area where organizations can ...
Breaking Medicine Technology:VAPETEK Releases CBD-Infused eLiquid For The Consumer Market 2New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2New Technologies Transforming Consumer Marketing Research Playbook 2
... treatment initiation and longer exposure to Betaseron ... sclerosis, MONTREAL, Sept. 19 Data ... Research in Multiple Sclerosis (WCTRIMS) demonstrated that,early ... a,greater impact on long-term outcomes, when compared ...
... 19 Novavax, Inc.,(Nasdaq: NVAX ) a clinical-stage ... Chief Executive Officer, will be presenting at,the 2008 UBS ... is being held September 22-25, 2008 at The Grand ... 2008 at 10:30 am.,Eastern Time. Dr. Singhvi will provide ...
Cached Medicine Technology:New Data Presented at WCTRIMS* Supports the Importance of Early and Sustained Treatment with Betaseron(R) 2New Data Presented at WCTRIMS* Supports the Importance of Early and Sustained Treatment with Betaseron(R) 3New Data Presented at WCTRIMS* Supports the Importance of Early and Sustained Treatment with Betaseron(R) 4New Data Presented at WCTRIMS* Supports the Importance of Early and Sustained Treatment with Betaseron(R) 5
(Date:7/11/2014)... 11, 2014 As transvaginal mesh ... Johnson & Johnson’s Ethicon Inc. unit continue to ... that the Texas Attorney General’s Office has acknowledged ... surgical mesh products used to treat pelvic organ ... report from kens5.com, the probe began nearly two ...
(Date:7/11/2014)... HealthDay Reporter THURSDAY, July 10, 2014 ... was thought to be cured by immediate and aggressive drug ... the AIDS-causing virus in her bloodstream, disappointed federal officials announced ... had remained virus-free even though she stopped taking HIV medications ... remission would open the door to a functional cure for ...
(Date:7/11/2014)... The report, “Specialty Synthetic Fibers & ... - 2018,” defines and segments the specialty synthetic ... and forecast of the volumes and values of ... meta aramids, UHMW Polyethylene, carbon fiber, partially oxidized ... fiber, PBO fiber, and liquid crystal polymer fiber ...
(Date:7/11/2014)... 11, 2014 Operators and ... billion in fuel costs now that model ... current GHG standards are phasing in ... upon themselves to install new features into ... reduction technologies , 2.    Efficient driveline components which ...
(Date:7/11/2014)... CA (PRWEB) July 11, 2014 Ticket Down ... at the Concord Pavilion . When it comes to the ... Luke Bryan. The 37-year-old Georgia native is one of the biggest ... the entertainment business. Bryan is currently out on his “That’s My ... the many stops the tour will be making through the rest ...
Breaking Medicine News(10 mins):Health News:Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing 2Health News:Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing 3Health News:Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing 4Health News:Mississippi Girl Thought Cured of HIV Shows Signs of Infection 2Health News:Mississippi Girl Thought Cured of HIV Shows Signs of Infection 3Health News:Specialty Synthetic Fibers & Glass Fiber Market Poised to Reach $20.1 Billion at a CAGR of 5.2% by 2018 – Report by MarketsandMarkets 2Health News:Specialty Synthetic Fibers & Glass Fiber Market Poised to Reach $20.1 Billion at a CAGR of 5.2% by 2018 – Report by MarketsandMarkets 3Health News:Specialty Synthetic Fibers & Glass Fiber Market Poised to Reach $20.1 Billion at a CAGR of 5.2% by 2018 – Report by MarketsandMarkets 4Health News:LeaseQ Agrees the Latest Round of Greenhouse Gas Rules Could Increase the Cost of Truck Acquisition and Maintenance 2Health News:LeaseQ Agrees the Latest Round of Greenhouse Gas Rules Could Increase the Cost of Truck Acquisition and Maintenance 3Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 2Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 3
... Oct. 8 Thousands of people around the world ... poetry and speak out to raise awareness and funds ... on Saturday, October 10, 2009. , "Discovering your Voice," ... 2009, stresses the need to hear the voices of ...
... Quantros, a leading provider of safety and quality ... industry, today announced significant updates to its Regulatory ... coincide with National Hospital Quality Measures (NHQM) updates ... will now include expanded tracking of venous thromboembolism ...
... Sysmex America, Inc. today announced that Tom Lindsay ... Sales. Lindsay will be responsible for sales strategy ... and retention of the company,s sales professionals. ... will focus on cross-functional collaboration that enables Sysmex to ...
... 8 American Laser Centers, the leading provider of aesthetic ... CEO, to oversee the continued growth and national expansion of ... ALC,s board of managers, and is responsible for the strategic ... the role of CEO from James McDermott. , American Laser ...
... The University of Guam received an $8,000,000 five-year ... to support a strong national cancer program aimed ... and the impact on minority populations. The grant ... research capabilities at the University of Guam, Increase ...
... Elsevier, a world-leading publisher of medical information products and ... Medical Press (PUMP) it has donated over 5,000 books ... The initiative is supported by the Development Centre for ... book donation is in line with the spirit of ...
Cached Medicine News:Health News:Discovering the Voice of Hospice and Palliative Care Worldwide: World Hospice and Palliative Care Day - October 10, 2009 2Health News:Quantros Expands RRM Solution With New Quality Measures 2Health News:Sysmex America Names National Sales Director 2Health News:American Laser Centers Names Health Care Veteran Steven Straus CEO 2Health News:University of Guam Cancer Research Center receives $8M grant 2Health News:Elsevier's Health Sciences Division and Peking University Medical Press cooperate on book donation 2
... to use instruments for nerve location: our ... stimulator, and muscle locator, together with a ... pencil point needles., ,The RDG Nerve ... to use stimulator, designed to facilitate the ...
... Based on the original MS-III ... electrosurgery certification, enhanced keypad ... ,The MiniStim® MS-IV peripheral ... for neuromuscular monitoring in operating ...
... beyond your investment., ,The Centiva/5 Critical Care ... time demands of the critical care environment. The ... mind combining a compact size with high levels ... valuable space around the patients bed and allows ...
... is combining a lightweight mesh material with the ... hernia plug which stands for a high patient ... material is included in Premilene Mesh LP Self-Forming ... for a softer and less bulky Plug Premilene ...
Medicine Products: